Takeda settles type 2 diabetes drugs patent infringement lawsuit in US
Takeda filed the lawsuits to enforce several patents that expire in 2016 relating to ACTOS, ACTOplus met, and duetact. Agreements have been reached with: Mylan, Alphapharm, Watson Pharmaceuticals,
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.